[e-drug] Special access to drugs for compassionate use (cont)

E-drug: Special access to drugs for compassionate use (cont)
---------------------------------------------
As an addendum to the reply from Barbara Mintzes, there is also no
requirement for anyone to collect data about the side effects, efficacy,
etc. for drugs given out under Canada's special authority procedure.

Joel Lexchin
--
Joel Lexchin MD
121 Walmer Rd.
Toronto, Ontario
Canada M5R 2X8
T: +416-964-7186
F: +416-923-9515
e mail: joel.lexchin@utoronto.ca
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.